Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Helicobacter pylori surface and thiol-containing enzymes represent a collective group of bacterial proteins essential for the survival, colonization, and pathogenesis of H. pylori in the human stomach. This group includes the critical enzyme urease, which neutralizes gastric acid via urea hydrolysis, and various redox-active enzymes like thioredoxin reductase (TrxR) and alkyl hydroperoxide reductase (AhpC) that protect the pathogen from oxidative stress (Tsang et al., 2011; Wang et al., 2015). These enzymes are primary targets for bismuth-containing therapeutic agents, such as bismuth subsalicylate and colloidal bismuth subcitrate, which exert antimicrobial effects by binding to functional thiol (sulfhydryl) groups (Ge & Sun, 2007). This binding leads to the irreversible inactivation of the enzymes and disrupts bacterial metabolism and cell wall integrity (Cun & Sun, 2010). Targeting these proteins is a cornerstone of multi-drug regimens used to treat peptic ulcers and prevent gastric cancer. The multi-target nature of these interactions helps reduce the likelihood of the bacterium developing resistance compared to single-target antibiotics (Ge & Sun, 2007).
Bismuth compounds bind with high affinity to the thiol groups of these enzymes, leading to irreversible inhibition of their catalytic activity and disruption of bacterial cell wall integrity and adherence (Ge & Sun, 2007; Tsang et al., 2011).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicobacter pylori surface and thiol-containing enzymes.